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Abstract
Background: Compared to the civilian population, military trainees are often at increased risk for respiratory
infections. We investigated an outbreak of radiologically-confirmed pneumonia that was recognized after 2 fatal
cases of serotype 7F pneumococcal meningitis were reported in a 303-person military trainee company (Alpha
Company).
Methods: We reviewed surveillance data on pneumonia and febrile respiratory illness at the training facility;
conducted chart reviews for cases of radiologically-confirmed pneumonia; and administered surveys and collected
nasopharyngeal swabs from trainees in the outbreak battalion (Alpha and Hotel Companies), associated training
staff, and trainees newly joining the battalion.
Results: Among Alpha and Hotel Company trainees, the average weekly attack rates of radiologically-confirmed
pneumonia were 1.4% and 1.2% (most other companies at FLW: 0-0.4%). The pneumococcal carriage rate among
all Alpha Company trainees was 15% with a predominance of serotypes 7F and 3. Chlamydia pneumoniae was
identified from 31% of specimens collected from Alpha Company trainees with respiratory symptoms.
Conclusion: Although the etiology of the outbreak remains unclear, the identification of both S. pneumoniae and
C. pneumoniae among trainees suggests that both pathogens may have contributed either independently or as
cofactors to the observed increased incidence of pneumonia in the outbreak battalion and should be considered
as possible etiologies in outbreaks of pneumonia in the military population.
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Military trainees are at increased risk for respiratory
infections compared to the general civilian population
[1]. Crowded living conditions and intense physical stress
may contribute to an increased risk for infections with
Streptococcus pneumoniae, Streptococcus pyogenes, Myco-
plasma pneumoniae, Chlamydia pneumoniae, Bordetella
pertussis, adenoviruses, and influenza viruses [1-3]. Out-
breaks of pneumococcal disease are relatively rare in the
general civilian population, but sporadic outbreaks of
pneumococcal pneumonia have been reported among
military trainees in the past [4-8]. We describe the inves-
tigation of an outbreak of radiologically-confirmed pneu-
monia in the setting of two fatal cases of pneumococcal
meningitis that occurred in February, 2009, at a Fort Leo-
nard Wood, MO military training facility. The findings of
this investigation provide information about the epide-
miology and microbiology of outbreaks of acute respira-
tory illness in military training populations and may
inform military health policy.
Methods
Setting
During February 6-14, 2009, two previously healthy mili-
tary trainees were diagnosed with S. pneumoniae meningi-
tis and subsequently died. Both trainees belonged to the
same company (Alpha Company, n = 303) in the 554
th Bat-
talion at Fort Leonard Wood U.S. Army Maneuver Support
Center of Excellence (FLW) training camp in Missouri.
During the same period of time (from February 6-14,
2009), an increase in the number of cases of radiologically-
confirmed pneumonia was also identified at FLW training
camp.
FLW training camp has a trainee population that typi-
cally ranges from 12,000-15,000 trainees during the win-
ter months, with new trainees entering and graduating
from the camp every two weeks. Trainees are sent to
FLW training camp to receive Initial Entry Training
(IET), Advanced Individual Training (AIT), or both. Trai-
nees undergoing IET belong to separate battalions and
reside in separate living quar t e r st h a nt r a i n e e su n d e r -
going AIT. In total, there are 13 battalions that are
further subdivided into 33 companies. Each battalion has
its own associated training staff, some of whom work clo-
sely with trainees despite living in separate training staff
quarters. Trainees arriving for IET at Fort Leonard
Wood receive antibiotic chemoprophylaxis with ben-
zathine penicillin G during their initial in-processing.
However, trainees transferring from other basic training
sites for AIT do not receive antibiotic chemoprophylaxis
upon arrival at FLW training camp, regardless of whether
or not they received prior chemoprophylaxis. In addition,
23-valent pneumococcal polysaccharide vaccine (PPV23)
is administered only to the small minority of individuals
with underlying illnesses that increase risk for pneumo-
coccal disease [9]. All trainees are required to receive
annual influenza vaccination.
Trainees of the 554
th Battalion are assigned to either
Alpha or Hotel Companies to undergo AIT in heavy
machinery operation. Alpha and Hotel companies are
housed separately and train separately.
Case definitions, case ascertainment, and surveillance
review
A case of pneumococcal meningitis was defined as a trai-
nee or training staff member in Alpha or Hotel Company
with symptoms consistent with meningitis and growth of
S. pneumoniae from cerebrospinal fluid during February
1-21, 2009. Cases were identified by review of hospital
records at FLW training camp and by referral from
civilian hospitals.
A case of radiologically-confirmed pneumonia was
defined as a trainee or training staff member in Alpha or
Hotel Company with a new infiltrate identified on chest
radiograph by the treating clinician or a radiologist from
February 1-21, 2009. Cases were identified through exist-
ing General Leonard Wood Army Community Hospital
(GLWACH) surveillance for radiologically-confirmed
pneumonia, which was conducted by reviewing the
weekly list of trainees deemed by a physician to be too ill
to participate in routine training and reviewing the elec-
tronic medical records of trainees on this list for docu-
mentation of radiologically-confirmed pneumonia. Using
a standardized data abstraction form, we reviewed the
medical charts of all patients with radiologically-con-
firmed pneumonia from companies with elevated rates of
pneumonia, and we collected data on symptoms of ill-
ness
1, past medical history, laboratory and diagnostic
testing, pertinent exam findings, and recent treatment
with antimicrobial medications.
The Naval Health Research Center (NHRC) conducts
surveillance year-round among trainees at FLW training
camp and seven other Department of Defense recruit-
ment training camps for febrile respiratory illness (FRI),
defined as temperature≥100.5°F with cough or sore
throat. Trainees that meet the criteria for FRI are
informed about the research volunteer program. Trainees
that volunteer to participate have nasal and throat swabs
collected and forwarded to NHRC where they are routi-
nely tested by polymerase chain reaction (PCR) for ade-
novirus and influenza A virus and by culture-based assay
for adenovirus, enterovirus, herpes simplex virus, parain-
fluenza 1-3, influenza A and B viruses, and respiratory
syncytial virus (RSV). We reviewed FRI surveillance data
from FLW training camp from January 1-February 17,
2009. During February 1-14, 2009, 17 nasal and throat
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and tested as part of routine FRI surveillance; none of
these were from Alpha or Hotel Company trainees. Dur-
ing February 15-16, 2009, GLWACH opened a special
clinic for trainees in the 554
th Battalion who were ill with
respiratory symptoms. Of 65 trainees from the 554
th Bat-
talion seen at the special clinic, a convenience sample of
37 trainees (57%) was selected to have nasal and throat
swab specimens collected; these specimens were sent to
N H R Cw h e r et h e yw e r et e s t e db yP C Rf o rm i m i v i r u s ,
bocavirus, Chlamydia pneumoniae, Mycoplasma pneu-
moniae, Streptococcus pneumoniae, Bordetella pertussis,
and Legionella pneumophila [10] in addition to under-
going testing for pathogens included in routine FRI
surveillance testing.
Cross-sectional survey
To assess the burden of respiratory illness during the
investigation period (February 1-21, 2009), we adminis-
tered a standardized survey to all trainees and training
staff of the 554
th Battalion. The survey collected demo-
graphic information and information on symptoms of
illness, healthcare utilization, influenza vaccination sta-
tus, and treatment with antibiotics during February 1,
2009 to the time of survey administration (February 18-
21, 2009). As a comparison group, we also administered
the same survey asking about the same time period to
all incoming Alpha Company trainees in the 554
th Bat-
talion on the day they arrived at the FLW training camp
from their homes in the civilian community.
To assess circulation of the pneumococcal strain that
caused the two cases of meningitis, we conducted a
cross-sectional survey of all Alpha company trainees,
training staff members, incoming trainees to the Alpha
Company, and, because of limited supplies, only the first
25 members of the Hotel Company. We collected cal-
cium alginate nasopharyngeal swabs, stored them in skim
milk, tryptone, glycerol, and glucose [11], and shipped
them overnight to CDC’s Streptococcal Reference
Laboratory. The skim milk, tryptone, glycerol, and glu-
cose media containing the NP samples were briefly
thawed and homogenized and 200 μl were inoculated in
5.0 ml of Todd Hewitt broth containing 0.5% yeast
extract supplemented with 1 ml of rabbit serum. After
4-6 hours of CO2 incubation at 37°C, 10 μlo ft h eb r o t h
were inoculated into blood-agar plates and incubated
overnight. S. pneumoniae colonies were identified mor-
phologically and confirmed using bile solubility and opto-
chin susceptibility. Confirmed isolates were serotyped by
Quellung reaction.
To assess the potential roles of other pathogens in the
outbreak, we obtained nasopharyngeal swabs and throat
swabs for viral and atypical bacterial pathogen testing
from Alpha and Hotel company trainees and incoming
Alpha company trainees with self-reported fever and
two or more respiratory symptoms within the preceding
72 hours. We also obtained an additional nasopharyn-
geal swab and throat swab for viral and atypical bacterial
pathogen testing from some symptomatic trainees who
did not meet these criteria. Throat swabs were collected
from all symptomatic and asymptomatic Alpha and
Hotel Company training staff members. Nasopharyngeal
swabs were tested for influenza A and B, RSV, parain-
fluenza 1-3, human metapneumovirus (hMPV), adeno-
virus, [12] and rhinovirus [12] by real-time PCR. Throat
swabs were tested for C. pneumoniae [13] and M. pneu-
moniae [14] by real-time PCR.
Human Subjects Review
The purpose of this investigation was to identify the
cause of the outbreak and to implement interventions to
prevent further cases from occurring. As such, the
investigation was not considered to be research and was
therefore exempt from human subjects review.
Statistical Analysis
Survey data were entered into a Microsoft Access 2003
database and analyzed using SAS 9.1 (SAS Institute Inc.,
Cary, NC). Chi-square and odds ratios with 95% confi-
dence intervals were calculated for trainee and training
staff characteristics hypothesized to be associated with
carriage or detection of pertinent pathogens.
Using denominators from the battalion, company, and
training staff rosters, weekly attack rates were calculated
for each battalion and company at FLW training camp
and for the training staff of the 554
th Battalion.
Results
Case-ascertainment and surveillance for meningitis,
radiologically-confirmed pneumonia, and FRI
The two cases of pneumococcal meningitis were the
only meningitis cases identified during the investigation
period, and both case-patients died (figure 1). Both
case-patients had confirmed infection with pneumococ-
cal serotype 7F which was fully susceptible to penicillin
(minimum inhibitory concentration ≤ 0.06 mcg/ml). For
both patients, blood cultures were negative, sputum cul-
tures revealed normal flora, and there was no evidence
of pneumonia on chest radiographs. Autopsies were not
performed.
Seventy-two cases of radiologically-confirmed pneu-
monia were identified among all trainees (N = approxi-
mately 9,400; approximate average weekly attack rate
0.3%) at FLW training camp during February 1-February
21. Of those 72 cases, 21 (29%) occurred among trainees
in the 554th Battalion (figure 1); 11 cases occurred in
Alpha Company (average weekly attack rate 1.4%), and
10 cases occurred in Hotel Company (average weekly
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lion, one (5%) was hospitalized, four (19%) had sputum
cultures sent at the time of diagnosis, and three (14%)
had blood cultures sent to the GLWACH laboratory at
the time of diagnosis; all sputum and blood cultures
were negative. None of the cases had urinary antigen
testing for S. pneumoniae. All 21 cases had chest radio-
graphs interpreted by the reviewing radiologist as having
evidence of lobar or lingular pneumonia. Of five trainees
with pneumonia from whom nasal and throat swabs
were obtained on the day of diagnosis as part of the spe-
cial clinic held by GLWACH for Alpha and Hotel com-
pany trainees, C. pneumoniae was identified by PCR
from four (80%); testing for other pathogens including
influenza viruses was negative.
During February 18-19, 2009, eleven of the Alpha and
Hotel Company trainees with radiologically-confirmed
pneumonia already treated with antibiotics had naso-
pharyngeal swab specimens sent to CDC for S. pneumo-
niae testing; of these, S. pneumoniae was isolated from
specimens from two trainees (18%; one serotype 7F, one
serotype 3). Seven Alpha and Hotel Company trainees
with radiologically-confirmed pneumonia already treated
with antibiotics had nasopharyngeal and throat swab
specimens sent to CDC for viral and atypical pathogen
testing; of these, C. pneumoniae was identified in speci-
mens from two (29%) trainees.
FRI was not increased at FLW training camp from
February 1-February 17, 2009. Of the 17 FRI specimens
collected from FLW training camp basic trainees during
this time as part of routine FRI surveillance, 6 (35%)
were positive for influenza A and none were positive for
C. pneumoniae.
Survey
Of the 533 trainees (99.6%) from the 554
th Battalion
who completed an investigation survey, the median age
was 22 years (range 17-51) and 20 (4%) had an underly-
ing medical condition (table 1). Most trainees (67%)
lived in “bays” (defined as rooms occupied by more than
four trainees). Only 28 (5%) trainees reported having
received PPV23 in the past, and of these, 16 (57%) had
an indication for PPV23 (two had asthma and 14 were
current smokers)
2. Receipt of PPV23 that occurred
before entering military service was not always docu-
mented in military medical records. Therefore, self-
reported pneumococcal vaccination status could not be
verified with military medical records.
Of the 533 surveyed Alpha and Hotel Company trai-
nees, only 103 (19%) did not have self-reported fever,
chills, or respiratory symptoms (defined as cough with
or without sputum, difficulty breathing, wheezing, runny
nose, sore throat, or ear pain) during February 1, 2009,
through the date of survey on February 18-19, 2009. Of
Figure 1 Cases of pneumococcal meningitis and radiologically-confirmed pneumonia in the 554th Battalion, Fort Leonard Wood, MO,
February 1-21, 2009.
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toms, cough was the most common symptom (69%), fol-
lowed by runny nose (66%) and sore throat (39%). Alpha
and Hotel Company trainees were significantly more
likely to report symptoms compared to the incoming
Alpha Company trainees (OR 5.2, CI 2.9-9.3) and to
training staff (OR 3.5, CI 2.4-5.3). Among surveyed trai-
nees, 149 (27%) trainees received antibiotics from Febru-
ary 1-19, 2009.
Of 299 specimens tested from Alpha Company trai-
nees, S. pneumoniae was isolated from 46 specimens
(15%) (figure 2). Of those 46 isolates, 45 isolates were
typeable (including 1 isolate containing 2 serotypes) and
10 serotypes were identified: 14 (30%) serotype 7F; 14
(30%) serotype 3; 6 (13%) serotype 23A, 5 (11%) sero-
type 7C, 2 (4%) serotype 17F, and 1 (2%) each of sero-
types 11A, 15A, 16F, 35F, and 38.
Specimens were obtained for pneumococcal testing
from 25 (12%) Hotel Company trainees. S. pneumoniae
was isolated from three specimens (overall carriage
12%). Of those three isolates, two were serotype 19A,
and one was serotype 1.
Of the 49 specimens obtained from incoming Alpha
Company trainees, S. pneumoniae was isolated from
three specimens (6%). Of those three isolates, two were
serotype 17F, and one was serotype 22F. Of the 131 spe-
cimens obtained from battalion training staff, S. pneu-
moniae w a si s o l a t e df r o mt w os p e c i m e n s( 2 % ) :o n e
serotype 11A, and one serotype 35B.
C. pneumoniae was identified in 19 of 61 (31%) speci-
mens obtained from Alpha Company trainees, 18 of 25
(72%) from Hotel Company trainees, 7 of 131 (5%) from
battalion training staff, and 2 of 49 (4%) from incoming
Alpha trainees. Of the 46 individuals with specimens
positive for C. pneumoniae, all had respiratory symp-
toms and/or self-reported fever within the two weeks
preceding swabbing.
Of the 37 specimens from Alpha Company trainees
tested for viral respiratory pathogens, viral pathogens
were identified from eight (22%) specimens: two with
influenza A, two with hMPV, two with RSV, and one
with both RSV and adenovirus. Of the 21 specimens
from Hotel Company, viral pathogens were identified
from two (10%) specimens: one with adenovirus and
one with hMPV.
Table 2 summarizes factors that were explored for
potential association with pneumococcal carriage and C.
pneumoniae detection. Taking antibiotics, living in a
“bay,” current smoking, and living on a particular floor
of the barracks were not significantly associated with
Table 1 Characteristics and symptoms of Alpha and Hotel Company trainees, battalion training staff, and incoming
trainees (N = 713)
Characteristic Alpha Company Hotel Company Training Staff Incoming Alpha
n = 301 n = 232 n = 131 n = 49
Median age (years) 22 22 37 22
Male 290 [96%] 213 [92%] 126 [96%] 49 [100%]
Underlying medical condition 6 [2%] 14 [6%] 21 [16%] 1 [2%]
Smoking status
Smoked > 100 cigarettes in lifetime 185 [61%] 146 [63%] 75 [57%] 38 [78%]
Currently smoke 163 [54%] 72 [31%] 50 [38%] 13 [27%]
Living quarters
Bay (> 4 trainees per room) 209 [69%] 148 [64%] N/A N/A
Smaller room (2-4 trainees per room) 90 [30%] 86 [37%] N/A N/A
Received 2008-09 influenza vaccine
a,b 271/276 [98%] 216/219 [99%] 92/122 [75%] 36/38 [95%]
Received pneumococcal vaccine
c 18 [6%] 10 [4%] 3 [2%] 6 [12%]
Symptoms February 1-19, 2009
At least 1 symptom
d 247 [82%] 183 [79%] 77 [59%] 23 [47%]
Cough 211 [70%] 156 [67%] 53 [40%] 12 [24%]
Runny Nose 195 [65%] 153 [66%] 53 [40%] 18 [37%]
Sore Throat 125 [42%] 82 [35%] 38 [29%] 7 [14%]
Fever 61 [20%] 45 [19%] 17 [13%] 2 [4%]
Chills 53 [18%] 39 [17%] 9 [7%] 0
Received antibiotics February 1-19, 2009 87 [29%] 62 [27%] 18 [14%] 5 [10%]
aAn individual was considered vaccinated against influenza for the current season if the individual received the 2008-09.
influenza vaccine > 14 days prior to participation in the cohort investigation.
bOf individuals who reported knowing their influenza vaccination status for the current season.
cSelf-reported history of receipt of pneumococcal vaccine.
dOf the following symptoms: fever, chills, cough with or without sputum, difficulty breathing, wheezing, runny nose, sore throat, or ear pain.
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addition, having one or more illness symptoms was not
significantly associated with pneumococcal carriage.
Interventions
From February 18-25, 2009, 301 of the 303 trainees cur-
rently in the Alpha Company, all 232 trainees in the
Hotel Company, 131 of the 178 battalion training staff
(i.e. those who opted to participate in the investigation),
and 49 of 52 incoming trainees to the Alpha Company
received 23-valent pneumococcal polysaccharide vaccine
(PPV23) and antibiotic prophylaxis (benzathine penicil-
lin G 1.2 million units given intramuscularly or azithro-
mycin 1 gram given orally for those with penicillin
allergy). In addition, hand hygiene and cough etiquette
were reviewed with all trainees and battalion training
staff.
Discussion
We describe an outbreak of radiologically-confirmed
pneumonia that was first recognized in a military train-
ing company after two fatal cases of pneumococcal
meningitis caused by serotype 7F occurred in the same
company. Overall, 15% of trainees in the 554
th Battalion
were colonized with pneumococcus, and serotypes 7F
and 3 were predominant. Colonization rates of 14-44%
have been documented among military personnel in the
setting of other pneumococcal outbreaks [4,7,8]. Because
pneumococcus is the most common bacterial cause of
pneumonia and meningitis in the United States, C.
pneumoniae detection among 44% of trainees tested was
unexpected and suggests a possible outbreak of C. pneu-
moniae infection in the same battalion.
Most adults with pneumonia, whether civilian or mili-
tary, do not undergo etiologic testing for pneumonia. Our
investigation began after 21 trainees in the 554
th Battalion
had already been diagnosed with pneumonia and treated
with antibiotics. Thus, the etiology of their pneumonia
remains unclear. Pneumococcus has been documented as
the primary etiologic agent in several outbreaks of pneu-
monia among military trainees described in the literature
[1,4-6,8,15]. During this outbreak of pneumonia at FLW
training camp, the isolation of pneumococcus serotype 7F
from the CSF of the two trainees with fatal meningitis
and the predominance of serotypes 7F and 3 among trai-
nees from their battalion may indicate that increased
pneumococcal transmission was occurring at the time of
the outbreak and provides some indirect support for
pneumococcus as a possible etiologic agent or cofactor in
the outbreak of pneumonia. However, blood cultures
were obtained at the time of pneumonia diagnosis from
only three trainees with pneumonia, all of whom had
Alpha Company
(n=303)
Hotel Company
(n=232)
Training Staff
(n=178)
Incoming Alpha 
Trainees
(n=52)
PPV-23
Antibiotic Prophylaxis
Screening Survey
OP Swab (Atypical Testing)
NP Swab (Pneumococcal Testing)
(n=131)
PPV-23
Antibiotic Prophylaxis
Screening Survey
OP Swab (Atypical Testing)
NP Swab (Pneumococcal Testing)
(n=49)
PPV-23
Antibiotic Prophylaxis
Screening Survey
(n=301)
PPV-23
Antibiotic Prophylaxis
Screening Survey
(n=232)
2/131 (2%) S. pneumoniae
7/131 (5%) C. pneumoniae
0 Both Pathogens
3/49 (6%) S. pneumoniae
2/49 (4%) C. pneumoniae
0 Both Pathogens
Alpha 
Company
(n=299)
46/299 (15%) 
S. pneumoniae
8/37 (22%) Viral Pathogen**
OP Swab For Viral 
Pathogen Testing 
(n=37)
NP Swab For 
Pneumococcal 
Carriage Survey 
(n=299)
*One specimen taken from either an Alpha or Hotel Company Soldier with a negative result for atypical pathogen testing 
could not be linked back to survey data or a specific company; 87 specimens from Alpha and Hotel Company Soldiers 
were tested for atypical pathogens but results for 86 specimens are presented here
**2 influenza A, 2 hMPV, 2 RSV, and 1 RSV and adenovirus 
***1 adenovirus, 1 hMPV
Swab for 
atypical 
testing 
(n=61)
19/61* (31%) 
C. pneumoniae
Hotel 
Company
(n=232)
3/25 (12%) 
S. pneumoniae
2/21 (10%) Viral Pathogen***
OP Swab For Viral 
Pathogen Testing 
(n=21)
NP Swab For 
Pneumococcal 
Carriage Survey 
(n=25)
Swab for atypical 
testing (n=25)
18/25* (72%) 
C. pneumoniae
Figure 2 Respiratory pathogen testing among Alpha and Hotel Company trainees, training staff, and incoming Alpha Company
trainees, Fort Leonard Wood, MO, February 2009.
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gen testing was not performed for any of the trainees with
pneumonia.
C. pneumoniae may have also played a role in this
outbreak of pneumonia, either as a primary etiologic
agent or as a cofactor, as suggested by the increased
prevalence of C. pneumoniae identification among trai-
nees in the battalion compared to training staff and
incoming trainees. C. pneumoniae is recognized as a
common cause of community acquired pneumonia in
young adults, and two outbreaks of pneumonia asso-
ciated with C. pneumoniae have been documented
among military recruits in Europe [3,16]. One study
conducted in a Finnish civilian population also sug-
gested that C. pneumoniae infection can predispose
individuals to subsequent infection with S. pneumoniae
[17].
Every year, approximately 68,500 individuals partici-
pate in training at FLW training camp, and typically
12,000-15,000 trainees are at the training camp at any
given time. The constant turn-over of trainees at mili-
tary training facilities poses a challenge for timely rate-
based surveillance at the company level because the
number of trainees at risk changes every one to two
weeks. In this investigation, the outbreak of pneumonia
among Alpha and Hotel Company trainees was
identified by the GLWACH medical command, in part
because of the two fatal cases of pneumococcal meningi-
tis, as well as through GLWACH’s surveillance for radi-
ologically-confirmed pneumonia. To facilitate outbreak
detection and response, including antibiotic prophylaxis
and vaccination when indicated, on-going, timely analy-
sis of surveillance data at the company level at military
training installations should be considered.
PPV23 and antibiotic prophylaxis, primarily with ben-
zathine penicillin G, were used in an attempt to halt
this outbreak because the serotype that caused the two
c a s e so fm e n i n g i t i si si n c l u d e di nP P V 2 3a n dw a ss u s -
ceptible to penicillin. In the absence of a control group
with similarly high attack rates of pneumonia, we were
unable to determine the effectiveness of PPV23 or che-
moprophylaxis in preventing further cases of pneumonia
or meningitis. PPV23 and antibiotic prophylaxis have
previously been used in other clusters of severe pneu-
mococcal infection [18] including in military settings
[4,6]. Since most PPV23 recipients require two weeks to
develop immunity after vaccination, antibiotic prophy-
laxis has been used as an adjunct in outbreak settings to
provide additional protection until immunity has devel-
oped. Antibiotic prophylaxis against pneumococcus can
also decrease nasopharyngeal colonization with pneumo-
coccus and decrease pneumococcal transmission.
Table 2 Factors associated with pneumococcal carriage or C. pneumoniae detection among Alpha and Hotel Company
trainees
S. pneumoniae positive S. pneumoniae negative OR (CI)
n = 49 n = 275
Receipt of antibiotics
a 7/37 (19%) 82/240 (34%) 0.4 (0.2-1.1)
“Bay” resident (> 4 trainees per room) 35 (71%) 191 (69%) 1.1 (0.6-2.2)
Current smoker 30 (61%) 142 (52%) 1.5 (0.8-2.8)
Floor of barracks
Floor 1 7/42 (17%) 64/233 (28%) 0.6 (0.2-1.6)
Floor 2 20/42 (47%) 87/233 (37%) 1.3 (0.6-2.6)
Floor 3 15/42 (36%) 82/233 (35%) 1 (Ref)
b
One or more symptoms
c 35 (71%) 229 (83%) 0.5 (0.3-1.0)
C. pneumoniae positive C. pneumoniae negative
d OR (CI)
n=3 7 n=4 8
Receipt of antibiotics
a 25 (69%) 34 (71%) 0.9 (0.3-2.3)
“Bay” resident (> 4 trainees per room) 30 (81%) 31 (65%) 2.4 (0.9-6.5)
Current smoker 18 (49%) 16 (33%) 1.9 (0.8-4.6)
Floor of barracks
Floor 1 2/34 (6%) 9/45 (20%) 0.2 (0-1.0)
Floor 2 11/34 (32%) 15/45 (33%) 0.6 (0.2-1.7)
Floor 3 21/34 (62%) 18/45 (40%) 1 (Ref)
b
aTrainee reported taking antibiotics during February 1-19, 2009.
bTrainees living on the 3rd floor of the barracks were used as the reference group for comparison with trainees living on the first and second floors of the
barracks.
cOf the following symptoms: fever, chills, cough with or without sputum, difficulty breathing, wheezing, runny nose, sore throat or ear pain.
d Two Alpha Company trainees with respiratory specimens that were negative for C. pneumoniae were not included in univariate analysis including one trainee
who had a sample that could not be linked back to the survey data and one trainee who gave a respiratory specimen but did not complete a survey.
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vention of pneumococcal disease. Vaccination with
PPV23 was provisionally recommended for smokers and
persons with asthma by the Advisory Committee on
Immunization Practices (ACIP) at the time of this inves-
tigation and is now officially recommended for these
groups by the ACIP [9]. The Military Vaccine Agency
does not recommend vaccination with PPV23 for all
military trainees but does offer the vaccine to those con-
s i d e r e da th i g hr i s ko fp n e u m o c o c c a li n f e c t i o n .T h e
potential licensure of pneumococcal conjugate vaccines
for adults in the United States may benefit military trai-
nees because such vaccines prevent colonization with
and transmission of vaccine-type pneumococci. The
advent of pneumococcal common protein vaccines,
which would provide protection against all serotypes of
S. pneumoniae, may offer another opportunity for pre-
vention of pneumococcal disease among military trai-
nees in the future [19].
Our investigation was subject to at least two limita-
tions. First, since our investigation began after the
majority of pneumonia cases had occurred in the 554
th
Battalion, we relied, in part, on diagnostic tests per-
formed by the treating clinician at the time of pneumo-
n i ad i a g n o s i st ot r yt oi d e n t i f yt h ee t i o l o g yo ft h e
outbreak of pneumonia, and these diagnostic tests were
not performed in a systematic manner. Second, since
this investigation was undertaken as part of a public
health response, we could not survey and obtain respira-
tory specimens from an unaffected training company
with a lower pneumonia attack rate for comparison to
trainees in the Alpha and Hotel companies. Inclusion of
s u c hac o m p a r i s o ng r o u pw o u l dh a v ep r o v i d e dd a t ao n
pneumococcal carriage and C. pneumoniae detection
rates among trainees with a lower rate of pneumonia
who were living and training under similar condition as
Alpha and Hotel company trainees.
Conclusions
We describe an outbreak of radiologically-confirmed
pneumonia and two fatal cases of pneumococcal menin-
g i t i st h a to c c u r r e da m o n gmilitary trainees and the
interventions that were made to halt the outbreak.
Because etiologic testing was not conducted among the
trainees with pneumonia at the time of pneumonia diag-
nosis, the etiology of the outbreak remains unclear.
However, S. pneumoniae and C. pneumoniae may have
both contributed independently or as cofactors to the
burden of respiratory illness observed among trainees.
Rate-based surveillance for pneumonia at the company-
level on military training installations may improve out-
break detection and timely response. In addition, new
pneumococcal vaccines may provide opportunities to
reduce the burden of pneumococcal disease among mili-
tary trainees in the future.
Endnotes
1 Defined as self-reported fever, chills, cough with or
without sputum, difficulty breathing, wheezing, runny
nose, sore throat, or ear pain.
2 Vaccination with PPV23 was provisionally recom-
mended for smokers and persons with asthma by the
Advisory Committee on Immunization Practices (ACIP)
at the time of this investigation.
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